Carbapenemase-Producing Gram Negative Bacilli (CPGNB) Infections
Surveillance results: 2015-2016

From April 1, 2015, to March 31, 2016, 73 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 3,749,277 patient days (Table 1). In total, four CPGNB infections were reported among patients who acquired their strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated CPGNB infection (cat. 1a and 1b) was 0.011 per 10,000 patient days. The acquisition rate of healthcare-associated CPGNB colonization (cat. 1a and 1b) was 0.197 per 10,000 patient days. Two teaching facilities and three non-teaching facilities participating last year did not participate this year whereas one teaching and nine non-teaching facilities were added. Data was extracted on May 31st, 2016.

Updated : March 1, 2017
Version française

Table 1 – Participation of Healthcare Facilities in the Surveillance of CPGNB Infections. Québec. 2015-2016

 

2014-2015

2015-2016

Participating facilities (N)

68

73

Admissions (N)

453,616

519,688

Inpatient days (N)

3,421,806

3,749,277

Cases of healthcare-associated CPGNB infection (cat. 1a and 1b) (N)

9

4

Cases of healthcare-associated CPGNB colonization (cat. 1a and 1b) (N)

58

74

Infected patients (cat. 1a + 1b) (N)

8

4

In 2015–2016, the incidence rate of healthcare-associated CPGNB infection (cat. 1a and 1b) was 0.011 per 10,000 patient days in all participating healthcare facilities (Table 2).

All reported infections occurred in teaching healthcare facilities (Table 2).

Table 2 – Incidence Rate and Percentile Distribution of Healthcare-Associated CPGNB Infection (Cat. 1a and 1b) by Type of Healthcare Facility, Québec, 2015–2016 (Incidence Rate per 10,000 Patient Days [95% CI])

Type of Facility

Min.

25 %

50 %

75 %

90 %

Max.

Taux d’incidence

Non-teaching (N = 51)

0

0

0

0

0

0

0

Teaching (N = 22)

0

0

0

0

0.097

0.233

0.020 [0.005 ; 0.045]¥

Total (N = 73)

0

0

0

0

0

0.233

0.011 [0.003 ; 0.024]

[I.C. 95%]: 95% confidence interval.
¥ Significant statistical difference (p < 0.05) between incidence rate in non-teaching and teaching healthcare facilities.

Among the 63 healthcare facilities participating in the two years of surveillance, the incidence rate of healthcare-associated CPGNB infections in 2015-2016 was 0.012 per 10,000 patient days and it was half the incidence rate observed in 2014-2015 (Table 3)

Table 3 – Change in Incidence Rate of Healthcare-Associated CPGNB infection (Cat1. 1a and 1b) by Type of Healthcare Facility, Québec, 2014-2015 to 2015–2016 (Incidence Rate per 10,000 Patient Days [95% CI])

 

2014-2015

2015-2016

Number of Infections

Incidence Rate

Number of Infections

Incidence Rate

Facilities

       

Non-teaching (N = 42)

1

0.007 [0 ; 0.027]

0

0

Teaching (N = 21)

8

0.042 [0.018 ; 0.076]

4

0.020 [0.005 ; 0.045]

Total (N = 63) *

9

0.027 [0.012 ; 0.047]

4

0.012 [0.003 ; 0.026]

* Number of facilities participating in each of the two years of surveillance.

In total, 98 colonizations (including 6 infections) of CPGNB were reported: 81 (82.6%) were identified in patients who acquired their CPGNB colonization during a current hospital stay (3 infections and 68 colonizations), during a previous hospital stay (1 infection and 2 colonizations) or in ambulatory care of the reporting facility (7 colonizations) (cat. 1a, 1b and 1c). One infection have been observed in a patient from the psychiatry unit. A total of 7 colonizations were associated to another facility (1 infection and 6 colonizations), to the community (7 colonizations) or remained unknown (2 colonizations) (cat. 2, 3 and 4) (Table 4).

Table 4 – Cases of CPGNB Infections and Colonizations by Presumed Origin of Acquisition, Québec, 2015–2016
(N, %)

Category

Origin of Acquisition

Infection

Colonization

1a

Healthcare-associated with a current hospital stay in the reporting facility 

3 (50.0%)

71 (72.4%)

1b

Healthcare-associated with a previous hospital stay in the reporting facility 

1 (16.7%)

3 (3.1%)

1c

Healthcare-associated with ambulatory care in the reporting facility 

0 (0%)

7 (7.1%)

1d

Healthcare-associated with long-term unit in the reporting facility

0 (0%)

0 (0%)

1e

Healthcare-associated with psychiatry unit in the reporting facility

1 (16.7%)

1 (1.0%)

2

Healthcare-associated with another facility

1 (16.7%)

7 (7.1%)

3

Community-associated

0 (0%)

7 (7.1%)

4

Unknown origin 

0 (0%)

2 (2.0%)

 

Total

6

98

Note: Colonizations included infections.

In 2015-2016, among 6 infections, no primary bloodstream infection (BSI) was observed (Table 5).

Table 5 – Number of Cases of CPGNB Infections from All Origins by Type of Infection and Number of all Origin CPGNB Secondary BSIs , Québec, 2015–2016 (N = 6)

Type of Infection

Infections (N)

Secondary Bloodstream Infections (N)

Primary BSI    
   CRBSI-MBI

0

-

   CRBSI

0

-

   Non-CRBSI-MBI

0

-

   Non-CRBSI

0

-

   HD

0

-

Others    
   Urinary tract

2

0

   Abdominal

0

0

   Pulmonary

2

0

   Surgical site

1

0

   Skin and soft tissue

0

0

   Bones and joints

1

0

   Others

0

0

Total

6

0

BSI: bloodstream infection.
CRBSI: catheter-related bloodstream infection.
MBI: mucosal barrier injury.
Non-CRBSI: non-catheter-related primary bloodstream infection.
HD: hemodialysis.

No deaths within 30 days were observed following onset of infection (Table 6).

Table 6– Number of Deaths and 30-days all Cause Case-fatality in Patients Infected by a CPGNB, Québec, 2015-2016

 

2014-2015

2015-2016

CPGNB infections (all origins)

13

6

Number of deaths

5

0

Case fatality

38.5%

0%

Table 7 – Risk Factors Associated With CPGNB Colonization, Québec, 2014-2015

Risk Factors

New Carrier
No contact with a known carrier

New Carrier
Contact with a known carrier

Known Carrier

Information not available on the carrier’s status

N

68

12

3

15

Contact with known carrier

0

12

0

4

Healthcare abroad (with or without hospitalization)

3

0

0

0

Travel abroad in the last 12 months

8

0

0

0

Other risks        
Carba-3GC*-Fluo

6

4

0

1

No Carba-3GC-Fluo

6

2

0

0

Diabetes

15

2

0

3

Acute renal failure

3

0

0

0

Chronic renal failure

5

0

0

1

Non hematologic active neoplasia

12

1

1

2

Solid organ transplant

2

1

0

0

* 3GC: 3rd generation cephalosporin.
Carba-3GC-Fluo: Taking a carbapenem/3rd generation cephalosporin/fluoroquinolone in the last two weeks prior to diagnosis.
No Carba-3GC-Fluo: not taking a carbapenem/3rd generation cephalosporin/fluoroquinolone in the last two weeks prior to diagnosis.

In 2015-2016, the acquisition rate of healthcare-associated CPGNB colonization (cat. 1a and 1b) was 0.215 per 10,000 patient days among healthcare facilities participating in the two years of surveillance (Table 8) and was 0.197 per 10,000 patient days among all facilities in 2015-2016 (Table 14).

Table 8 – Change in the Number of Cases and Acquisition Rate of Healthcare-associated CPGNB Colonization (Cat. 1a and 1b) by Type of Healthcare Facility, Québec, 2014-2015 to 2015-2016 (Acquisition Rate of Healthcare-Associated CPGNB Colonization per 10,000 patient days)

Type of Facility

2014-2015

2015-2016

Number of Colonizations

Acquisition Rate of HA-CPGNB Colonization

Number of Colonizations

Acquisition Rate of HA-CPGNB Colonization

Non-teaching (N = 42)

33

0.228 [0.157 ; 0.312]

50

0.343 [0.254 ; 0.445]

Teaching (N = 21)

25

0.130 [0.084 ; 0.186]

24

0.121 [0.077 ; 0.174]

Total (N = 63) *

58

0.172 [0.131 ; 0.219]

74

0.215 [0.169 ; 0.267]

* Number of facilities participating in each of the two years of surveillance.

Table 9 shows the number of non-teaching facilities that indicated the type of screening used at admission (non-teaching: 34 out of 51; teaching: 14 out of 22) and during hospitalization (non-teaching: 27 out of 51; teaching: 16 out of 22).

Table 9 – Number of Healthcare Facilities that Indicated the Type of Screening Procedure Used at Admission and During Hospitalization by Type of Facility, Québec, 2015-2016

 

Number of Facilities That Indicated the Number of Screening Procedure Used*

At Admission

During Hospitalization

Not Indicated

Total

Non-teaching (N = 51)

34

27

9

37

Teaching (N = 22)

14

16

4

18

Total (N = 73)

48

43

13

55

* The "at admission" and "during hospitalization" categories are not mutually exclusives

Tables 10 and 11 feature the total number of screening tests performed at admission and during hospitalization, as well as the mean number of CPGNB screening tests per admission.

Table 10 – Total Number of Screening Tests Performed at Admission and During Hospitalization by Type of Healthcare Facility, Québec, 2015-2016

Type of Facility

Total Number of Screening Procedures

At Admission

During Hospitalization

Not Indicated

Total

Non-teaching

9,602

17,048

304

26,954

Teaching

14,814

20,916

1,618

37,348

Total

24,416

37,964

1,922

64,302

Table 11 – Mean Number of CPGNB Screening Tests by Type of Healthcare Facility, Québec, 2014-2015 (Mean CPGNB Screening Tests per Admission), Québec, 2015-2016

Type of Facility

Mean Number of CPGNB Screening Tests*

At Admission

During Hospitalization

Total

Non-teaching

0.038

0.068

0.108

Teaching

0.055

0.077

0.138

Total

0.047

0.073

0.124

* The "at admission" and "during hospitalization" categories are not mutually exclusives.

Figure 1 features the distribution of microorganisms isolated from all cases. A total of 111 microorganisms have been isolated from 98 colonizations. Identified microorganisms were Citrobacter freundii (44.1%), Klebsiella pneumonia (17.1%), Enterobacter cloacae (16.2%) or Escherichia coli (10.8%). For seven colonization cases, two microorganisms have been isolated, whereas for one colonization, a total of four distinct microorganisms have been isolated.

Figure 1 – Categories of Isolated Microorganisms for all Cases (n = 67), Québec, 2015-2016

Isolated Microorganisms - All Cases (n = 111)

Table 12 presents the proportion of tested strains for sensitivity or resistance to carbapeneme (doripenem, ertapenem, imipenem and meropenem) as well as percentage of resistance among isolated strains.

All the Enterobacter cloacae, Citrobacter freundii, Klebsiella oxytoca, Klebsiella pneumoniae and Serratia marcescens were ertapenem resistant.

Table 12 – Resistance Profile Towards Carbapenem of CPGNB Microorganisms Isolated, Québec, 2015-2016

Microorganism

Isolated

Tested

Resistants

N

Antibiotique

N

%

N

%

Acinetobacter baumannii

2

Imipénem

1

50.0%

1

100.0%

   

Méropénem

1

50.0%

1

100.0%

Citrobacter freundii

49

Doripénèm

1

2.0%

1

100.0%

   

Ertapénem

46

93.9%

46

100.0%

   

Imipénem

3

6.1%

2

66.7%

   

Méropénem

49

100.0%

48

98.0%

Enterobacter cloacae

18

Ertapénem

17

94.4%

17

100.0%

   

Imipénem

7

38.9%

7

100.0%

   

Méropénem

17

94.4%

17

100.0%

Escherichia coli

12

Ertapénem

11

91.7%

10

90.9%

   

Imipénem

9

75.0%

9

100.0%

   

Méropénem

12

100.0%

12

100.0%

Klebsiella oxytoca

6

Ertapénem

5

83.3%

5

100.0%

   

Imipénem

4

66.7%

4

100.0%

   

Méropénem

4

66.7%

4

100.0%

Klebsiella pneumoniae

19

Ertapénem

19

100.0%

19

100.0%

   

Imipénem

12

63.2%

12

100.0%

   

Méropénem

19

100.0%

19

100.0%

Serratia marcescens

3

Ertapénem

2

66.7%

2

100.0%

   

Imipénem

1

33.3%

1

100.0%

 

 

Méropénem

2

66.7%

2

100.0%

Citrobacter species

2

Ertapénem

2

100.0%

2

100.0%

 

 

Méropénem

2

100.0%

2

100.0%

Note: Only microorganisms that have been tested for an antibiotic are represented.

Table 13 shows the carbapenemase gene detected for every isolated microorganisms. The majority of carbapenemase gene associated to different microorganism is KPC. One strain of Enterobacter cloacae, six strains of Escherichia coli and two strain of Klebsiella pneumoniae produced NDM. One Klebsiella pneumonia strain produced both OXA-48 and NDM.

Table 13 – Distribution of Carbapenemase-encoding Genes from Reported Microorganisms, Québec, 2015-2016

Microorganism

Isolated

Gene

Gene frequencye

N

%

Acinetobacter baumannii

2

OXA-23

1

50.0

Citrobacter freundii

49

KPC

47

95.9

   

OXA-48

2

4.1

Citrobacter species

2

KPC

2

100.0

Enterobacter cloacae

18

KPC

15

83.3

   

NDM

1

5.6

   

NMC

1

5.6

Escherichia coli

12

KPC

6

50.0

   

NDM

6

50.0

Klebsiella oxytoca

6

KPC

5

83.3

Klebsiella pneumoniae

19

KPC

14

73.7

   

OXA-48

2

10.5

   

NDM

2

10.5

   

NDM / OXA-48

1

5.3

Serratia marcescens

3

KPC

1

33.3

 

 

SME

1

33.3

KPC : Klebsiella pneumoniae carbapenemase (Class A).
NDM : New-dehli metallo-b-lactamase (Class B).
NMC : Not metalloenzyme carbapenemase.
OXA-23 : Oxacillinase-23 (class D).
OXA-48 : Oxacillinase-48 (Class D).
SME : Serratia marcescens enzyme.

The incidence rate of healthcare-associated CPGNB infection and the percentile rankings by type of facility are shown in figure 2 and 3. Figure 4 and 5 present the rate of acquisition of healthcare-associated CPGNB colonization by type of facility.

Figure 2 – Incidence Rate and Percentile Ranking of Healthcare-Associated CPGNB infection (Cat. 1a and 1b) for Non-Teaching Healthcare Facilities, Québec, 2015-2016 (Incidence Rate per 10,000 Patient Days)

NB: Non-teaching facilities reported no cases of infection in 2015-2016.

Figure 3 – Incidence Rate and Percentile Ranking of Healthcare-Associated CPGNB Infection (Cat. 1a and 1b) for Teaching Healthcare Facilities, Québec, 2015-2016 (Incidence Rate per 10,000 Patient Days)

NB: Facilities 2, 3, 5, 8, 12, 13, 15, 18, 20, 21, 24, 27, 28, 29, 30, 31, 33, 76 and 118 did not report any cases of infection in 2015-2016.

Figure 4 – Acquisition Rate of Healthcare-Associated CPGNB Colonization (Cat.1a and 1b) for Non-Teaching Healthcare Facilities, Québec, 2015-2016 (Acquisition Rate of Healthcare-Associated CPGNB Colonization per 10,000 Patient Days)

NB: Facilities 9, 11, 16, 23, 26, 32, 34, 35, 37, 39, 40, 42, 44, 45, 46, 47, 49, 51, 52, 53, 56, 59, 61, 65, 67, 70, 71, 74, 75, 77, 81, 82, 84, 85, 86, 88, 89, 91, 97, 99, 100, 101, 103, 107, 109, 112, 113 and 130 did not report any cases of colonization in 2015-2016.

Figure 5 – Acquisition Rate of Healthcare-Associated CPGNB Colonization (Cat.1a and 1b) for Teaching Healthcare Facilities, Québec, 2015-2016 (Acquisition Rate of Healthcare-Associated CPGNB Colonization per 10,000 Patient Days)

NB: Facilities 3, 8, 12, 13, 15, 18, 20, 28, 30, 31, 76 and 118 did not report any cases of colonization in 2015-2016.

At the local level, in 2015-2016, the incidence rate of healthcare-associated CPGNB infections ranged from 0 to 0.233 per 10,000 patient days, whereas the acquisition rate of healthcare-associated CPGNB colonization ranged from 0 to 6,603 per 10,000 patient days. A total of 60 facilities (82%) did not report any healthcare-associated CPGNB infection or colonization in 2015-2016. A detailed summary of the surveillance data for HA-CPGNB infection by healthcare facility can be found in table 14.

Table 14 – Incidence Rate of Healthcare-Associated CPGNB Infection (cat. 1a and 1b), Acquisition Rate of Healthcare-Associated CPGNB Colonization and Mean CPGNB Screening Tests by Admission and by Facility, Québec, 2015-2016 (Incidence Rate per 10,000 Patient Days [95% CI]; Acquisition Rate of Colonization per 10,000 Patient Days)

HR

Facility

 

Incidence Rate of HA-CPGNB Infection (cat. 1a and 1b) [95% CI]

Acquisition Rate of HA-CPGNB Colonization (cat. 1a and 1b) [95% CI]

Mean CPGNB Screening Tests per Admission*

Number

Name

1

16

HÔPITAL RÉGIONAL DE RIMOUSKI

0

0

0.083

32

CENTRE HOSPITALIER RÉGIONAL DU GRAND-PORTAGE

0

0

0.056

61

HÔPITAL NOTRE-DAME-DE-FATIMA

0

0

0.079

71

HÔPITAL DE MATANE

0

0

0.035

77

HÔPITAL D'AMQUI

0

0

0

84

HÔPITAL DE NOTRE-DAME-DU-LAC

0

0

0.037

 

 

BAS-SAINT-LAURENT

0

0

0.061

2

20

HÔPITAL DE CHICOUTIMI

0

0

0.001

67

HÔPITAL ET CENTRE DE RÉADAPTATION DE JONQUIÈRE

0

0

0.013

74

HÔPITAL DE DOLBEAU-MISTASSINI

0

0

0.005

88

HÔPITAL. CLSC ET CENTRE D'HÉBERGEMENT DE ROBERVAL

0

0

0

100

HÔPITAL DE LA BAIE

0

0

0

112

HÔPITAL D'ALMA

0

0

0

 

 

SAGUENAY–LAC-SAINT-JEAN

0

0

0.002

3

2

HÔPITAL DE L'ENFANT-JÉSUS

0

0.078

0.077

7

PAVILLON L'HÔTEL-DIEU DE QUÉBEC

0.233 [0.022 ; 0.668]

0.582

0.103

24

HÔPITAL DU SAINT-SACREMENT

0

0.184

0.026

27

PAVILLON CENTRE HOSPITALIER DE L'UNIVERSITÉ LAVAL

0

0.084

0.017

28

PAVILLON SAINT-FRANCOIS D'ASSISE

0

0

0.023

33

INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC

0

0.105

0.112

59

HÔPITAL DE BAIE-SAINT-PAUL

0

0

0.014

86

HÔPITAL DE LA MALBAIE

0

0

0.009

 

 

CAPITALE-NATIONALE

0.034 [0.003 ; 0.097]

0.153

0.057

4

23

HÔTEL-DIEU D'ARTHABASKA

0

0

0.008

31

PAVILLON SAINTE-MARIE

0

0

0.002

41

HÔPITAL DU CENTRE-DE-LA-MAURICIE

-

-

-

44

HÔPITAL SAINTE-CROIX

0

0

0.034

85

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX DU HAUT-SAINT-MAURICE

0

0

0

 

 

MAURICIE ET CENTRE-DU-QUÉBEC

0

0

0.011

5

15

HÔPITAL FLEURIMONT

0

0

0

30

HOTEL-DIEU DE SHERBROOKE

0

0

0

46

HÔPITAL DE GRANBY

0

0

0

49

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX MEMPHRÉMAGOG

0

0

0

75

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX DU GRANIT

0

0

0

99

HÔPITAL BROME-MISSISQUOI-PERKINS

0

0

0.001

 

 

ESTRIE

0

0

0

6

3

GLEN - ROYAL VICTORIA

0

0

0.052

4

HÔPITAL NOTRE-DAME DU CHUM

0.097 [0 ; 0.381]

0.195

0.046

5

HÔPITAL GÉNÉRAL JUIF

0

0.535

1.375

6

GLEN - ENFANTS

-

-

-

8

PAVILLON MAISONNEUVE/PAVILLON MARCEL-LAMOUREUX

0

0

0.001

12

CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE

0

0

0

13

INSTITUT DE CARDIOLOGIE DE MONTRÉAL

0

0

0.064

21

HÔPITAL SAINT-LUC DU CHUM

0

0.099

0.063

22

HÔTEL-DIEU DU CHUM

0.161 [0 ; 0.630]

0.161

0.076

25

HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL

-

-

-

26

HÔPITAL DE VERDUN

0

0

0.005

29

HÔPITAL GÉNÉRAL DE MONTRÉAL

0

0.259

0.218

34

HÔPITAL SANTA CABRINI

0

0

0

36

HÔPITAL GÉNÉRAL DU LAKESHORE

-

-

-

38

HÔPITAL JEAN-TALON

-

-

-

48

CENTRE HOSPITALIER DE ST. MARY

-

-

-

76

HOPITAL DE LACHINE

0

0

0

80

HÔPITAL FLEURY

-

-

-

83

HÔPITAL DE LASALLE

-

-

-

118

HÔPITAL NEUROLOGIQUE DE MONTRÉAL

0

0

0.027

 

 

MONTRÉAL

0.019 [0.002 ; 0.054]

0.141

0.246

7

39

HÔPITAL DE GATINEAU

0

0

0.001

40

HÔPITAL DE HULL

0

0

0.005

51

HÔPITAL DE MANIWAKI

0

0

0

95

HÔPITAL DU PONTIAC

-

-

-

111

HÔPITAL DE PAPINEAU

-

-

-

 

 

OUTAOUAIS

0

0

0.002

8

47

HÔPITAL DE ROUYN-NORANDA

0

0

0.003

52

HÔPITAL D'AMOS

0

0

0

65

HÔPITAL ET CLSC DE VAL-D'OR

0

0

0.005

70

CENTRE DE SOINS DE COURTE DURÉE LA SARRE

0

0

0

82

PAVILLON SAINTE-FAMILLE

0

0

0.015

 

 

ABITIBI-TÉMISCAMINGUE

0

0

0.002

 

64

HÔPITAL LE ROYER

-

-

-

9

72

HÔPITAL ET CENTRE D'HÉBERGEMENT DE SEPT-ÎLES

-

-

-

 

 

CÔTE-NORD

-

-

-

10

96

CENTRE DE SANTÉ DE CHIBOUGAMAU

-

-

-

 

 

NORD-DU-QUÉBEC

-

-

-

11

53

HÔPITAL DE CHANDLER

0

0

0

91

HÔPITAL HÔTEL-DIEU DE GASPÉ

0

0

0.229

97

HÔPITAL DE MARIA

0

0

0.114

107

HÔPITAL DE L'ARCHIPEL

0

0

0.039

109

HÔPITAL DE SAINTE-ANNE-DES-MONTS

0

0

0.074

 

 

GASPÉSIE–ÎLES-DE-LA-MADELEINE

0

0

0.100

12

18

HÔTEL-DIEU DE LÉVIS

0

0

0.028

63

HÔPITAL DE SAINT-GEORGES

0

1.274

0.385

89

HÔPITAL DE MONTMAGNY

0

0

0.014

113

HÔPITAL DE THETFORD MINES

0

0

0.018

 

 

CHAUDIÈRE-APPALACHES

0

0.324

0.118

13

19

HÔPITAL CITÉ DE LA SANTÉ

0

0.293

0.132

 

 

LAVAL

0

0.293

0.132

14

11

HÔPITAL PIERRE-LE GARDEUR

0

0

0.017

 

14

CENTRE HOSPITALIER RÉGIONAL DE LANAUDIÈRE

-

-

-

 

 

LANAUDIÈRE

0

0

0.017

15

45

HÔPITAL DE SAINT-EUSTACHE

0

0

0.004

56

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX D'ARGENTEUIL

0

0

0.050

81

HÔPITAL DE MONT-LAURIER

0

0

0.059

101

HÔPITAL RÉGIONAL DE SAINT-JÉRÔME

0

0

0.003

103

HÔPITAL LAURENTIEN

0

0

0.003

 

 

LAURENTIDES

0

0

0.008

16

1

HÔPITAL CHARLES LEMOYNE

-

-

-

9

HÔPITAL DU HAUT-RICHELIEU

0

0

0

10

HÔPITAL PIERRE-BOUCHER

-

-

-

35

HÔPITAL HONORÉ-MERCIER

0

0

0.016

37

HÔTEL-DIEU DE SOREL

0

0

0

42

CENTRE HOSPITALIER ANNA-LABERGE

0

0

0.101

58

HÔPITAL DU SUROÎT

0

6.603

2.038

130

HÔPITAL BARRIE MEMORIAL

0

0

1.211

 

 

MONTÉRÉGIE

0

1.167

0.385

 

 

Total

0.011 [0.003 ; 0.024]

0.197

0.124

* Number of screening test divided by number of admissions.
-    Healthcare facilities that did not participate in 2015-2016.
HR: Health region.

Comité de surveillance provinciale des infections nosocomiales (SPIN)

Editorial committee

Christophe Garenc, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Danielle Moisan, Centre hospitalier régional du Grand-Portage

Muleka Ngenda-Muadi, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Mélissa Trudeau, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Isabelle Rocher, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Christian Lavallée, Hôpital Maisonneuve-Rosemont

Jasmin Villeneuve, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

File Version EPUB (216.47 KB)

Add new comment

HTML filtré

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

Texte brut

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.